Skip to main content

Prevalence of extraintestinal manifestations in ulcerative colitis and associated risk factors

Indian Journal of Gastroenterology volume 40, pages 477–482 (2021)Cite this article

Abstract

Background

The data on prevalence of extraintestinal manifestations (EIM) in ulcerative colitis (UC) are  scanty and highly variable.

Methods

Consecutive patients with UC were prospectively evaluated from November 2016 to August 2017. A detailed history was obtained and physical examination was done. Presence of EIM was confirmed by a consultant rheumatologist, ophthalmologist and dermatologist. Tests performed were hemogram, liver function test, abdominal ultrasound, slit lamp examination, X-ray and magnetic resonance imaging when deemed necessary.

Results

A total of 227 patients with UC were enrolled in this study. The prevalence of EIM was 7.92%. Mucocutaneous (4.84%) manifestations were the commonest, followed by musculoskeletal (1.32%) and ocular (0.88%). Hepatobiliary (0.44%) and vascular (0.44) manifestations were present in equal frequency. History of appendicectomy was associated with  EIM.

Conclusion

The prevalence of EIM in UC was low in our study. History of appendicectomy was a risk factor for EIM.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Zippi M, Corrado C, Pica R, et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol. 2014;20:17463–7.

  2. Singh B, Kedia S, Konijeti G, et al. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: frequency and relation with disease phenotype. Indian J Gastroenterol. 2015;34:43–50.

  3. Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci. 1999;44:1–13.

    Article  CAS  Google Scholar 

  4. Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003;9:2300–7.

  5. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116–22.

    Article  CAS  Google Scholar 

  6. Habeeb MA, Rajalingam R, Dhar A, Kumar A, Sharma MP, Mehra NK. HLA association and occurrence of autoantibodies in Asian-Indian patients with ulcerative colitis. Am J Gastroenterol. 1997;92:772-6.

  7. Ricart E, Panaccione R, Loftus EV, et al. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis. 2004;10:207–14.

    Article  Google Scholar 

  8. Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–9.

  9. Harbord M, Annese V, Vavricka SR, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10:239–54.

  10. Orchard TR, Chua CN, Ahmad T, Cheng H, Welsh KI, Jewell DP. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology. 2002;123:714-8.

  11. Hedin CRH, Vavricka SR, Stagg AJ, et al. The pathogenesis of extraintestinal manifestations: implications for IBD research, diagnosis and therapy. J Crohns Colitis. 2019;13:541–54.

  12. Verbraak FD, Schreinemachers MC, Tiller A, van Deventer SJ, de Smet MD. Prevalence of subclinical anterior uveitis in adult patients with inflammatory bowel disease. Br J Ophthalmol. 2001;85:219-21.

  13. Bandyopadhyay D, Bandyopadhyay S, Ghosh P, et al. Extraintestinal manifestations in inflammatory bowel disease: prevalence and predictors in Indian patients. Indian J Gastroenterol. 2015;34:387–94.

  14. Mendoza JL, Lana R, Taxonera C, Alba C, Izquierdo S, Díaz-Rubio M. Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis. Med Clin (Barc). 2005;125:297-300.

  15. Karmiris K, Avgerinos A, Tavernaraki A, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis. 2016;10:429–36.

  16. Algaba A, Guerra I, Ricart E et al. Extraintestinal manifestations in patients with inflammatory bowel disease: study based on the ENEIDA registry. Dig Dis Sci. 2021;66:2014-23.

  17. Kochhar R, Mehta SK, Nagi B, et al. Extraintestinal manifestations in idiopathic ulcerative colitis. Indian J Gastroenterol. 1991;10:88–9.

  18. Pokharna RK, Kabra PK, Sharma R, Kochar DK. Extraintestinal manifestations of idiopathic ulcerative colitis in northwestern India. Indian J Gastroenterol. 2004;23:89–90.

    CAS  PubMed  Google Scholar 

  19. Makharia GK, Ramakrishna BS, Abraham P, et al. Survey of inflammatory bowel diseases in India. Indian J Gastroenterol. 2012;31:299–306.

    Article  Google Scholar 

  20. Amarapurkar AD, Amarapurkar DN, Rathi P, et al. Risk factors for inflammatory bowel disease: A prospective multi-center study. Indian J Gastroenterol. 2018;37:189–95.

  21. Sharma JB, Sharma B, Sharma R, Mahajan SK, Raina R, Sharma P. The profile of inflammatory bowel disease in natives of western Himalayas. Trop Gastroenterol. 2017;38:115–21.

  22. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl.1989;170:2-6.

  23. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A.

  24. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625–9.

    Article  CAS  Google Scholar 

  25. Alnaqbi KA, Touma Z, Passalent L, et al. Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease. J Rheumatol. 2013;40:1726–35.

  26. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut. 1964;5:1–15.

  27. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42:387–91.

    Article  CAS  Google Scholar 

  28. Philip M, Augustine P, Thomas V, et al. Multi-center prospective survey of inflammatory bowel diseases in Kerala: More than 2000 cases. Indian J Gastroenterol. 2017;36:459–67.

    Article  Google Scholar 

  29. Card TR, Langan SM, Chu TP. Extra-gastrointestinal manifestations of inflammatory bowel disease may be less common than previously reported. Dig Dis Sci. 2016;61:2619–26.

    Article  Google Scholar 

  30. Park SK, Wong Z, Park SH, et al. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: a multinational study. Dig Liver Dis. 2021;53:196–201.

    Article  Google Scholar 

  31. Evans J, Sapsford M, Raine T, et al. AB0719 Prevalence of undiagnosed axial spondyloarthritis in patient with inflammatory bowel disease: a systemic literature review and primary research study. Ann Rheum Dis. 2019;78:1822–3.

    Google Scholar 

  32. Chopra A. Disease burden of rheumatic diseases in India: COPCORD perspective. Indian J Rheumatol. 2015;10:70–7.

    Article  Google Scholar 

  33. Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777–83.

  34. De Marco G, McGonagle D, Lettieri G, et al. MRI assessment of axial involvement in inflammatory bowel disease related SpA: age at the disease diagnosis, not extent and severity of axial disease relates to  HLA-B27. Ann Rheum Dis. 2016;75:331.

  35. Maksymowych WP. The role of imaging in the diagnosis and management of axial spondyloarthritis. Nat Rev Rheumatol. 2019;15:657–72.

    Article  CAS  Google Scholar 

  36. de Winter J, de Hooge M, van de Sande M, et al. Magnetic resonance imaging of the sacroiliac joints indicating sacroiliitis according to the assessment of spondyloarthritis international society definition in healthy individuals, runners, and women with postpartum back pain. Arthritis Rheum. 2018;70:1042–8.

  37. Tibdewal P, Bhatt P, Jain A, Gupta D, Bhatia S, Shukla A. Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India. Indian J Gastroenterol. 2019;38:295-302.

Download references

Author information

Authors and Affiliations

  1. Prime Institute of Digestive Sciences, Panchvati Main Road, Rajkot, 360 004, India

    Krishn Kant Rawal & Varun P. Shukla

  2. Milestone Hospital, Vidyanagar Main Road, Rajkot, 360 002, India

    Shabbir Chikani

  3. Retina Care Centre, Virani Chowk, Vidyanagar Main Road, Rajkot, 360 002, India

    Milan Thakkar

  4. Devarsh, 13-Manhar Plot, Mangala Main Road, Rajkot, 360 002, India

    Mukesh Ruparelia

  5. Department of Community Medicine, PDU Government Medical College, Rajkot, 360 001, India

    Rajesh K. Chudasama

Authors
  1. Krishn Kant Rawal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Varun P. Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shabbir Chikani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Milan Thakkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mukesh Ruparelia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rajesh K. Chudasama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Krishn Kant Rawal.

Ethics declarations

Conflict of interest

KKR, VPS, SC, MT, MR, and RKC declare that they have no conflict of interest.

Ethics statement

The study was performed in a manner to conform to the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.

The study was conducted after obtaining proper ethical clearance from the ethics committee.

Disclaimer

The authors are solely responsible for the data and the content of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/ findings and content of this article.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rawal, K.K., Shukla, V.P., Chikani, S. et al. Prevalence of extraintestinal manifestations in ulcerative colitis and associated risk factors. Indian J Gastroenterol 40, 477–482 (2021). https://doi.org/10.1007/s12664-021-01181-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-021-01181-9

Keywords

  • Aphthous ulcer
  • Appendicectomy
  • Crohn’s disease
  • Inflammatory bowel disease
  • Mayo classification
  • Primary sclerosing cholangitis
  • Spondyloarthritis
  • Thrombosis
  • Uveitis